PARLIAMENTARY WRITTEN QUESTION
Selective Serotonin Reuptake Inhibitors (21 October 2022)

We continue to work with the suppliers of selective serotonin reuptake inhibitors (SSRIs), including citalopram and fluoxetine, to ensure continuity of supply. With the Medicines and Healthcare products Regulatory Agency, we are supporting suppliers to bring stock to the United Kingdom market and engaged with industry to ensure stock remains available to meet demand.

While we are aware of supply issues with some SSRIs, including fluoxetine 10 milligram tablets, fluoxetine 10 milligram capsules remain available. A Serious Shortage Protocol has been issued to allow community pharmacists to supply capsules where tablets have been prescribed. The majority of SSRIs remain available for pharmacies to purchase via the usual wholesaler routes.